1. Diagnostic and prognostic value of long noncoding RNAs as biomarkers in urothelial carcinoma
   Johanna Droop et al, 2017, PLoS ONE CrossRef
2. Noncoding RNAs in Cancer Diagnosis.
   Mu-Sheng Zeng, 2016, Adv Exp Med Biol CrossRef
3. Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets
   Cecilia Pop-Bica et al, 2017, IJMS CrossRef
4. Short-Term Alcohol Abstinence Improves Antibacterial Defenses of Chronic Alcohol-Consuming Mice against Gut Bacteria–Associated Sepsis Caused by Enterococcus faecalis Oral Infection
   Makiko Kobayashi et al, 2017, The American Journal of Pathology CrossRef
5. M2b macrophage polarization accompanied with reduction of long noncoding RNA GAS5
   Ichiaki Ito et al, 2017, Biochemical and Biophysical Research Communications CrossRef
6. Serum HOTAIR and GAS5 levels as predictors of survival in patients with glioblastoma
   Jie Shen et al, 2017, Mol Carcinog CrossRef
7. Prognostic Values of Long Noncoding RNA GAS5 in Various Carcinomas: An Updated Systematic Review and Meta-Analysis
   Qunjun Gao et al, 2017, Front. Physiol. CrossRef
8. Long non-coding RNA expression in bladder cancer
   Mohammad Taheri et al, 2017, Biophys Rev CrossRef
9. mRNA, microRNA and lncRNA as novel bladder tumor markers
   Edyta Wieczorek et al, 2018, Clinica Chimica Acta CrossRef
10. Long Non-coding RNAs Expression in Renal Cell Carcinoma
    M. Taheri et al, 2017, JBTW CrossRef
11. Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription.
    Miao Wang et al, 2018, Cell Death Dis CrossRef
12. Long noncoding RNAs in cancer cells
    Duc-Hiep Bach et al, 2018, Cancer Letters CrossRef
13. Cell-free lncRNA expression signatures in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer
    Lutao Du et al, 2018, J Cell Mol Med CrossRef
14. Long non-coding RNA GAS5 aggravates hypoxia injury in PC-12 cells via down-regulating miR-124
    Xiaoli Hu et al, 2018, J. Cell. Biochem. CrossRef
15. Survival of Mice with Gastrointestinal Acute Radiation Syndrome through Control of Bacterial Translocation
    Fujio Suzuki et al, 2018, J.I. CrossRef
16. Long noncoding RNA GAS5 regulates the proliferation, migration, and invasion of glioma cells by negatively regulating miR-18a-5p.
    Qian Liu et al, 2018, J Cell Physiol CrossRef
17. Knockdown of long non-coding RNA linc00511 suppresses proliferation and promotes apoptosis of bladder cancer cells via suppressing Wnt/β-catenin signaling pathway
    Jun Li et al, 2018, Biosci. Rep. CrossRef
18. Dual biomarkers long non-coding RNA GAS5 and microRNA-34a co-expression signature in common solid tumors.
    Eman A Toraih et al, 2018, PLoS One CrossRef
19. Epigenetic Alterations in Bladder Cancer
    Sima P. Porten, 2018, Curr Urol Rep CrossRef
20. Loss of GAS5 tumour suppressor lncRNA: an independent molecular cancer biomarker for short-term relapse and progression in bladder cancer patients
    Margaritis Avgeris et al, 2018, Br J Cancer CrossRef
21. M2b macrophage polarization and its roles in diseases
    Le-xun Wang et al, 2018, J Leukoc Biol CrossRef
22. Growth arrest specific transcript 5 in tumorigenesis process: An update on the expression pattern and genomic variants
    Soudeh Ghaforui-Fard et al, 2019, Biomedicine & Pharmacotherapy CrossRef
23. Long non-coding RNAs in genitourinary malignancies: a whole new world
    Ronan Flippot et al, 2019, Nat Rev Urol CrossRef
24. Up-regulated lncRNA GAS5 promotes chemosensitivity and apoptosis of triple-negative breast cancer cells.
    Juntao Li et al, 2019, Cell Cycle CrossRef
25. Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma
    Hui Zhang et al, 2017, Cancer Chemother Pharmacol CrossRef
26. Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers.
    Daniela Terracciano et al, 0 CrossRef
27. An androgen reduced transcript of LncRNA GAS5 promoted prostate cancer proliferation.
    Yingyi Zhang et al, 0 CrossRef
28. Glycyrrhizin Protects γ-Irradiated Mice from Gut Bacteria–Associated Infectious Complications by Improving miR-222–Associated Gas5 RNA Reduction in Macrophages of the Bacterial Translocation Site
    Ichiaki Ito et al, 2020, J.I. CrossRef
29. The Roles of lncRNA in Cutaneous Squamous Cell Carcinoma
    Yujia Wang et al, 2020, Front. Oncol. CrossRef
30. The Non-Coding RNA Repressor GAS5 of the Glucocorticoid Receptor: Insights to Its Role in Human Malignancies
    , 2020, Med One CrossRef
31. Comprehensive analysis of differentially expressed lncRNAs as diagnostic and prognostic markers for colorectal cancer
    Xunlei Zhang et al, 2019, Exp Ther Med CrossRef
32. Long non‑coding RNA GAS5 regulates myocardial ischemia‑reperfusion injury through the PI3K/AKT apoptosis pathway by sponging miR‑532‑5p
    Yang Han et al, 2020, Int J Mol Med CrossRef
33. CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands.
    Jan Korbecki et al, 2020, Int J Mol Sci CrossRef
34. LncRNA GAS5 Inhibits Cellular Proliferation by Targeting P27Kip1
    Gang Luo et al, 2017, Mol Cancer Res CrossRef
35. Chemokine (C-C Motif) Ligand 1 Derived from Tumor-Associated Macrophages Contributes to Esophageal Squamous Cell Carcinoma Progression via CCR8-Mediated Akt/Proline-Rich Akt Substrate of 40 kDa/Mammalian Target of Rapamycin Pathway.
    Masataka Fujikawa et al, 2021, Am J Pathol CrossRef
36. Chemokines as the critical factors during bladder cancer progression: an overview
    Amir Sadra Zangouei et al, 2021, International Reviews of Immunology CrossRef
37. Long non-coding RNA GAS5 suppresses rheumatoid arthritis progression via miR-128-3p/HDAC4 axis
    Tao Peng et al, 2021, Mol Cell Biochem CrossRef
38. Long Noncoding RNAs as Innovative Urinary Diagnostic Biomarkers
    Giulia Brisotto et al, 2021 CrossRef
39. Long Noncoding RNA Small Nucleolar Host Gene: A Potential Therapeutic Target in Urological Cancers
    Zitong Yang et al, 2021, Front. Oncol. CrossRef
40. Hepatic F4/80 + CD11b + CD68 – cells influence the antibacterial response in irradiated mice with sepsis by Enterococcus faecalis
    Norio Okamoto et al, 2021, J Leukoc Biol CrossRef
41. Long Noncoding RNA GAS5 Inhibits Tumorigenesis and Enhances Radiosensitivity by Suppressing miR-135b Expression in Non-Small Cell Lung Cancer
    Yingbo Xue et al, 2017, oncol res CrossRef
42. Long Noncoding RNAs Regulate the Inflammatory Responses of Macrophages
    Qing Zhao et al, 2021, Cells CrossRef
43. Integration of chemokine signaling with non-coding RNAs in tumor microenvironment and heterogeneity in different cancers
    Shweta Arora et al, 2022, Seminars in Cancer Biology CrossRef
44. Overexpression of long intergenic noncoding RNAs in bladder cancer: A new insight to cancer diagnosis
    Zahra Ousati Ashtiani et al, 2022, Pathology - Research and Practice CrossRef
45. Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1/LATS2/YAP1 signaling pathway in colorectal cancer
    Xi Liu et al, 2022, Cancer Cell Int CrossRef
46. Long Non-Coding Mitochondrial RNAs as Novel Molecular Target for Bladder Cancer Treatment
    Jaime Villegas O. et al, 2022 CrossRef
47. Non-coding RNA and autophagy: Finding novel ways to improve the diagnostic management of bladder cancer
    Ishaq Tantray et al, 2023, Front. Genet. CrossRef
48. Identification of prognostic and therapeutic value of CC chemokines in Urothelial bladder cancer: evidence from comprehensive bioinformatic analysis.
    Yuxin Li et al, 2021, BMC Urol CrossRef
49. Tumor-Associated Macrophage Subsets: Shaping Polarization and Targeting.
    Qindong Zhang et al, 2023, Int J Mol Sci CrossRef
50. Role of Long Non-coding RNAs on Bladder Cancer
    Hui-Jin Li et al, 2021, Front. Cell Dev. Biol. CrossRef
51. Epigenetic and Immunological Features of Bladder Cancer
    Irina Gilyazova et al, 2023, IJMS CrossRef
52. m6A-mediated upregulation of lncRNA RMRP boosts the progression of bladder cancer via epigenetically suppressing SCARA5
    Xinsheng Lu et al, 2023, Epigenomics CrossRef
53. Exploring the impact of miR-128 in inflammatory diseases: A comprehensive study on autoimmune diseases
    Ria Margiana et al, 2023, Pathology - Research and Practice CrossRef
54. Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies
    Amirreza Mehmandar-Oskuie et al, 2023, Biomedicine & Pharmacotherapy CrossRef
55. Tumor-associated macrophages: an effective player of the tumor microenvironment
    Udit Basak et al, 2023, Front. Immunol. CrossRef
56. Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism
    Mehrdad Hashem et al, 2024, Non-coding RNA Research CrossRef
57. Sensing antibody functions with a novel CCR8-responsive engineered cell
    Jianyu Hao et al, 2024, Acta Biochim. Pol. CrossRef
58. Exploring the versatility of miRNA-128: a comprehensive review on its role as a biomarker and therapeutic target in clinical pathways
    Dipa K. Israni et al, 2024, Mol Biol Rep CrossRef
59. GAS5 long non-coding RNA interacts with microRNA-205 to relieve fibroblast-like synoviocyte inflammation and ferroptosis in osteoarthritis
    Yanglin Gu et al, 2024, Apoptosis CrossRef